Interleukin-2 therapy in relapsed acute myelogenous leukemia.
Meloni G, Vignetti M, Pogliani E, Invernizzi R, Allione B, Mirto S, Sica S, Leoni F, Selleri C, Mandelli F.
Meloni G, et al.
Cancer J Sci Am. 1997 Dec;3 Suppl 1:S43-7.
Cancer J Sci Am. 1997.
PMID: 9457393
Clinical Trial.